Related Experiment Video
Updated: Mar 15, 2026
03:53
Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management
Published on: March 15, 2024
3.1K
Developing an algorithm for cost-effective, clinically judicious management of peripheral nerve tumors
Harjus Birk1, Corinna C Zygourakis2, Michel Kliot3
1School of Medicine, University of California, San Francisco, California, USA; Department of Neurological Surgery, University of California, San Francisco, CA, USA.
Surgical Neurology International
|September 15, 2016
Summary
Peripheral nerve tumors like neurofibromas and schwannomas are often benign. This study proposes a cost-effective management plan for asymptomatic cases, identifying which patients need surgery versus observation with imaging.
Area of Science:
- Neurology
- Oncology
- Medical Imaging
Background:
- Peripheral nerve tumors, including neurofibromas and schwannomas, are increasingly detected due to advancements in imaging like MRI neurography and ultrasound.
- Most peripheral nerve tumors are benign, necessitating careful consideration for managing asymptomatic lesions.
Discussion:
- A cost-effective management paradigm is proposed for asymptomatic peripheral nerve neurofibromas and schwannomas.
- This paradigm integrates economic analyses to guide clinical decision-making.
- It aims to differentiate patients who would benefit from surgical intervention versus conservative management.
Key Insights:
- The study focuses on optimizing the management of asymptomatic peripheral nerve tumors.
- It provides a framework for making cost-effective decisions regarding clinical exams and serial imaging.
- Identifying patients who truly require surgery is a central outcome.
Outlook:
- Further validation of this cost-effective management paradigm in diverse clinical settings.
- Potential for integration into clinical guidelines for peripheral nerve tumor management.
- Long-term economic impact assessment of the proposed strategy.
